Germantown-based biotech company Intrexon Corp. has acquired a San Diego-based company for $26 million.
According to CityBizList, the Maryland synthetic biology company bought Medistem Inc., which has led the development of “universal donor adult stem cells that stimulate new blood vessel formation and are capable of generating different tissues.”
In spring 2013, Intrexon raised more than $85 million in a new round of funding, preparation for its $160 million IPO, which happened in August. Founded in 1998, Intrexon so far is unprofitable.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
